Advertisement News Archives - Page 12 of 5155 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

March 28, 2024

Santhera’s vamorolone NDA receives priority review in China

Santhera Pharmaceuticals has reported that the China National Medical Products Administration (NMPA) granted priority review for a new drug application (NDA) for vamorolone, for Duchenne muscular dystrophy (DMD).

Santhera’s vamorolone NDA receives priority review in China